The BBI Clinical Research Proteomics Platform is a collaborative resource that develops and provides access to next-generation clinical proteomic assays, for example using Multiple Reaction Monitoring Mass Spectrometry (MRM). The Platform is led by Dr. Amanda Paulovich, a Member of the Clinical Research Division at Fred Hutchinson Cancer Research Center. Watch a video and see the Paulovich Laboratory website for more info on the capabilities available to the CRPP.